Nida center for genetic studies. March 14, 2023 - march 13, 2028. N01DA-23-7787. Administrative novation from contract no. 75N95023D00009.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95025D00005
- Awardee
-
Infinity Biologix LLC UEI NPUACRBK7TV9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $5,670,437 obligated
Award facts
- Opportunity
-
- NIDA Center for Genetic Studies Pre-Solicitation · 75N95022R00097 · Posted Aug 15, 2022
- Combined order value
- $5,670,437 Current and potential, with all options
- Last date to order 72% complete
- IDV ceiling 38% used
- $15,000,000.00
- Maximum order
- $15,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a single-award indefinite-delivery contract to Infinity Biologix LLC for the NIDA Center for Genetic Studies on March 14, 2023, with a ceiling value of $15,000,000 and an ultimate completion date of March 13, 2028.
Work is performed at Infinity Biologix's facility in Piscataway, New Jersey. The IDIQ procures advanced genomic sequencing, DNA analysis, and biorepository services to support the agency's substance use disorder research initiatives through genetic studies.
The contract runs on a five-year performance period from March 14, 2023 through March 13, 2028. The solicitation was posted August 15, 2022 with a due date of October 13, 2022, and the IDIQ resulted from an administrative novation from contract number 75N95023D00009.
Two delivery orders have been issued under this IDIQ. Task order 75N95025F00001 (TO3), awarded March 14, 2025, is valued at $2,712,502.66 and runs through March 13, 2026 on a firm-fixed-price basis. Task order 75N95026F00001 (TO4), awarded March 14, 2026, is valued at $2,957,934 and extends through March 13, 2027, also firm-fixed-price. Both orders are performed at the Piscataway facility with no socioeconomic set-aside applied.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95025D00005?
75N95025D00005 was awarded to Infinity Biologix LLC by National Institute on Drug Abuse (National Institutes of Health) on March 14, 2023.
How much is contract 75N95025D00005 worth?
Orders under 75N95025D00005 have obligated $5,670,437. 75N95025D00005's own ceiling is $15,000,000. A single order can be worth up to $15,000,000.
How many orders have been placed under contract 75N95025D00005?
2 orders have been placed under 75N95025D00005, the latest on March 14, 2026.
Who can order from contract 75N95025D00005?
75N95025D00005 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95025D00005 competed?
The extent of competition for 75N95025D00005 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV